Immunovant Inc (IMVT)
27.23
-0.58%
Immunovant Inc (IMVT) is currently trading at $27.23. This represents a loss of 0.58% from the previous session. With a market capitalization of $5.54B, IMVT is a key component of the Health Care sector. Investors looking to trade IMVT should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade IMVT commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Immunovant Inc (IMVT) shows a bearish trend. Analysts are watching the 29.25 level closely.
Fundamentals
Mkt Cap5.54B
P/E Ratio0.0000
Volume1,884,083
60-Day Technical Chart
Advanced Charting
Need more indicators for IMVT? Use the world's #1 platform.
Open IMVT on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $27
| Metric |
IMVT -0.58% |
T -1.69% |
PFE -0.18% |
TTD +0.88% |
|---|---|---|---|---|
| Price | $27.23 | $27.87 | $27.09 | $25.16 |
| Mkt Cap | $5.54B | $195.11B | $154.03B | $12.17B |
| - | View → | View → | View → |
Latest Headlines
Assessing Immunovant (IMVT) Valuation As Shares Deliver A 25% One Year Return
Yahoo Finance • Feb 23, 2026
Immunovant, Inc. (IMVT) Stock Analysis: Unpacking A 51% Potential Upside
DirectorsTalk Interviews • Feb 25, 2026
Immunovant (Nasdaq: IMVT) raises $550M to support potential IMVT-1402 Graves’ launch
Stock Titan • Dec 11, 2025
Immunovant (IMVT) Stock News and Forecast for Dec. 14, 2025: $550M Financing Closes, Roivant Buys $350M, Analysts Update Targets
TechStock² • Dec 14, 2025
Roivant Sciences buys Immunovant (IMVT) shares worth $349.9m
Investing.com • Dec 12, 2025
● Gemini Agentic AI Analyst Insight for IMVT
Market Education
- I am a newbie Trader, how do I start trading Jul 15, 2023
- Finding Stocks in the Squeeze Zone: Using Finviz Jul 30, 2023
- Stock Valuation Dec 16, 2023
External Research